Basilea Pharm Allsch Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BASILEA PHARM ALLSCH, and what generic and branded alternatives to BASILEA PHARM ALLSCH drugs are available?
BASILEA PHARM ALLSCH has one approved drug.
Summary for Basilea Pharm Allsch
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Basilea Pharm Allsch
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basilea Pharm Allsch | ZEVTERA | ceftobiprole medocaril sodium | POWDER;INTRAVENOUS | 218275-001 | Apr 3, 2024 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Basilea Pharm Allsch | ZEVTERA | ceftobiprole medocaril sodium | POWDER;INTRAVENOUS | 218275-001 | Apr 3, 2024 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
